Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the best cheap biotech stocks to buy now. Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Inc. (CPRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Third Avenue Management Martin Whitman | 0 | $0 | 0% | |
| 2. | Neo Ivy Capital Renee Yao | 0 | $0 | 0% | |
| 3. | Quantinno Capital Hoon Kim | 0 | $0 | 0% | |
| 4. | Persistent Asset Partners Xin Huang | 0 | $0 | 0% | |
| 5. | Athos Capital Matthew Moskey And Friedrich Schulte-Hillen | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.99 | 7,000 | $20,930.00 | 560,376 | 2020-09-30 | Filing | |
| $2.97 | 15,000 | $44,550.00 | 4,787,693 | 2020-09-30 | Filing | |
| $4.70 | 10,000 | $46,950.00 | 553,376 | 2019-10-11 | Filing | |
| $4.89 | 10,000 | $48,900.00 | 4,772,693 | 2019-10-03 | Filing | |
| $3.23 | 25,000 | $80,750.00 | 4,762,693 | 2019-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.06 | 6,746 | $155,562.76 | 2,360 | 2025-12-12 | Filing | |
| $23.73 | 4,473 | $106,162.18 | 9,106 | 2025-12-12 | Filing | |
| $23.20 | 15,527 | $360,195.35 | 13,579 | 2025-12-12 | Filing | |
| $23.33 | 10,983 | $256,244.37 | 3,962 | 2025-11-26 | Filing | |
| $22.70 | 40,000 | $908,000.00 | 231,039 | 2025-11-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,823 | $403,027 | 0% | |
| 2. | 1,781 | $55,977 | 0% | |
| 3. | 1,533 | $48,175 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
12 Cheap Biotech Stocks to Buy Now
In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now. On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2025 Earnings Call Transcript
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2025 Earnings Call Transcript February 26, 2026 Operator: Good morning, and thank you for standing by.
Catalyst Pharmaceuticals, Inc. (CPRX): A Bull Case Theory
We came across a bullish thesis on Catalyst Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on CPRX.
7 Stocks on Jim Cramer’s Radar Recently
Jim Cramer, the host of Mad Money, on Tuesday talked about the opening days of earnings season and the market’s uneven behavior. “The market gets so angry over nothing.
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Catalyst Pharmaceuticals, Inc.
12 Cheap Healthcare Stocks to Buy Heading into 2026
In this article, we will take a look at the cheap healthcare stocks to buy heading into 2026.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q3 2025 Earnings Call Transcript
Catalyst Pharmaceuticals, Inc.
What do Analysts Think About Catalyst Pharmaceuticals (CPRX)?
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the best biotech stocks with high potential. HC Wainwright reiterated a Buy rating on Catalyst Pharmaceuticals, Inc.
14 Biotech Stocks with High Potential
In this article, we will look at the top 14 Biotech Stocks with High Potential.
Hedge Fund Resource Center